Ovarian cancer with peritoneal metastases has many treatment options and HIPEC is here to stay
- PMID: 33970163
- PMCID: PMC8100724
- DOI: 10.21037/jgo-2020-17
Ovarian cancer with peritoneal metastases has many treatment options and HIPEC is here to stay
Conflict of interest statement
Conflicts of Interest: Both authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/jgo-2020-17). The focused issue was sponsored by the Peritoneal Surface Oncology Group International (PSOGI). Drs. PHS and KVDS served as the unpaid Guest Editors of the focused issue. The authors have no other conflicts of interest to declare.
Comment on
-
Narrative review of cytoreductive surgery and intraperitoneal chemotherapy for peritoneal metastases in ovarian cancer.J Gastrointest Oncol. 2021 Apr;12(Suppl 1):S137-S143. doi: 10.21037/jgo-20-274. J Gastrointest Oncol. 2021. PMID: 33968434 Free PMC article. Review.
-
Intraperitoneal chemotherapy for ovarian cancer with peritoneal metastases, systematic review of the literature and focused personal experience.J Gastrointest Oncol. 2021 Apr;12(Suppl 1):S144-S181. doi: 10.21037/jgo-2020-06. J Gastrointest Oncol. 2021. PMID: 33968435 Free PMC article. Review.
-
Narrative review of hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with advanced ovarian cancer: a critical reappraisal of the current evidence.J Gastrointest Oncol. 2021 Apr;12(Suppl 1):S182-S188. doi: 10.21037/jgo-20-130. J Gastrointest Oncol. 2021. PMID: 33968436 Free PMC article. Review.
References
Publication types
LinkOut - more resources
Full Text Sources